Abstract
Multidrug resistance of Gram-negative bacilli is a major problem globally. However, little is known about the combined probability of resistance to various antibiotics. In this study, minimum inhibitory concentrations of widely used antibiotics were determined using clinical isolates of Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii, randomly chosen from strain collections created during 1999–2009 in tertiary medical institutions in Seoul, South Korea. To analyze combined efficacy of antibiotics against a subgroup of isolates, conditional probabilities were determined based on arbitrary, non-independent patterns of antimicrobial susceptibility and resistance. Multidrug resistance, defined as resistance to three or more classes of antibiotics, was observed in the following order: A. baumannii (96%), P. aeruginosa (65%), E. coli (52%), and K. pneumoniae (7%). A. baumannii strains resistant to gentamicin were found to be resistant to a number of antibiotics, except for colistin and polymyxin B. Resistance to gentamicin following exposure to this antibiotic was highly likely to lead to multidrug resistance in all four microbes. This study shows a causal relationship between gentamicin resistance and the prevalence of multidrug resistance in clinical isolates of Gramnegative bacilli in South Korea during 1999–2009 and suggests the importance of prudent use of gentamicin in hospitals.
Article PDF
Similar content being viewed by others
References
Austin, D.J., Bonten, M.J., Weinstein, R.A., Slaughter, S., and Anderson, R.M. 1999. Vancomycin-resistant enterococci in intensivecare hospital setting: Transmission dynamics, persistence, and the impact of infection control programs. Proc. Natl. Acad. Sci. USA 96, 6908–6913.
Barclay, M.L. and Begg, E.J. 2001. Aminoglycoside adaptive resistance: importance for effective dosage regimens. Drugs 61, 713–721.
Barclay, M.L., Begg, E.J., and Chambers, S.T. 1992. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob. Agents Chemother. 36, 1951–1957.
Calva, J.J., Sifuentes-Osornio, J., and Cerón, C. 1996. Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico. Antimicrob. Agents Chemother. 40, 1699–1702.
Ciofu, O., Riis, B., Pressler, T., Poulsen, H.E., and Høiby, N. 2005. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother. 49. 2276–2282.
D’Agata, E.M.C. 2004. Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study. Infect. Contr. Hospit. Epidemiol. 25, 842–846.
Daikos, G.L. and Jackson, G.G. 1990. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J. Infect. Dis. 162, 414–420.
Davies, J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science 264, 375–382.
Davies, J. and Wright, G.D. 1997. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 5, 234–240.
Dordel, J., Kim, C., Chung, M., de la Gandara, M.P., Holden, M.T.J., Parkhill, J., de Lencastre, H., Bentley, S.D., and Tomasz, A. 2014. Novel determinants of antibiotic resistance: identification of mutated loci in highly methicillin-resistant subpopulations of methicillin-resistant Staphylococcus aureus. mBio 5, e01000-13.
Falagas, M.E., Bliziotis, I.A., Kasiakou, S.K., Samonis, G., Athanassopoulou, P., and Michalopoulos, A. 2005. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect. Dis. 5, 24.
Falagas, M.E. and Kasiakou, S.K. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin. Infect. Dis. 40, 1333–1341.
Fischbach, M.A. and Walsh, C.T. 2009. Antibiotics for emerging pathogens. Science 325, 1089–1093.
Fluit, A.C., Visser, M.R., and Schmitz, F.J. 2001. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14, 836–871.
Garnacho-Montero, J., Ortiz-Leyba, C., Jiménez-Jiménez, F.J., Barrero-Almodóvar, A.E., Garcia-Garmendia, J.L., Bernabeu-Wittell, M., Gallego-Lara, S.L., and Madrazo-Osuna, J. 2003. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin. Infect. Dis. 36, 1111–1118.
Gieske, C.G., Monnet, D.L., Cars, O., and Carmeli, Y. 2008. Clinical and economic impact of common multidrug-resistant Gramnegative bacilli. Antimicrob. Agents Chemother. 52, 813–821.
Gilliver, M.A., Bennett, M., Begon, M., Hazel, S.M., and Hart, C.A. 1999. Enterobacteria: antibiotic resistance found in wild rodents. Nature 401, 233–234.
Hawkey, P.M. and Jones, A.M. 2009. The changing epidemiology of resistance. J. Antimicrob. Chemother. 64 (Suppl 1), i3–i10.
Honoré, N. and Cole, S.T. 1994. Streptomycin resistance in mycobacteria. Antimicrob. Agents Chemother. 38, 238–242.
Jana, S. and Deb, J.K. 2006. Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 70, 140–150.
Kang, Y.S. and Park, W. 2010. Trade-off between antibiotic resistance and biological fitness in Acinetobacter sp. strain DR1. Environ. Microbiol. 12, 1304–1318.
Karlowsky, J.A., Hoban, D.J., Zelenitsky, S.A., and Zhanel, G.G. 1997. Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 40, 371–376.
Klevens, R.M., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L.H., Lynfield, R., Dumyati, G., Townes, J.M., et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298, 1763–1771.
Lee, J.H., Song, J.H., and Ko, K.S. 2011. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea. Microb. Drug Resist. 17, 299–304.
Li, J., Nation, R.L., Turnidge, J.D., Milne, R.W., Coulthard, K., Rayner, C.R., and Paterson, D.L. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589–601.
Lipsitch, M., Bergstrom, C.T., and Levin, B.R. 2000. The epidemiology of antibiotic resistance in hospitals: paradoxes and predictions. Proc. Natl. Acad. Sci. USA 97, 1938–1943.
MacDougall, C. and Chambers, H.F. 2011. Aminoglycosides, pp. 1505–1520. In Brunton, L., Chabner, B.A., and Knollmann, B.C. (eds.), Goodman & Gilman’s the pharmacological basis of therapeutics, 12th ed. McGraw-Hill, New York, USA.
Mammina, C., Di Carlo, P., Cipolla, D., Giuffrè, M., Casuccio, A., Di Gaetano, V., Plano, M.R.A., D’Angelo, E., Titone, L., and Corsello, G. 2007. Surveillance of multidrug-resistant Gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am. J. Infect. Control. 35, 222–230.
Meier, A., Kirschner, P., Bange, F.C., Vogel, U., and Böttger, E.C. 1994. Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob. Agents Chemother. 38, 228–233.
Mingeot-Leclercq, M.P., Glupczynski, Y., and Tulkens, P.M. 1999. Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43, 727–737.
Mohamed, A.F., Nielsen, E.I., Cars, O., and Friberg, L.E. 2011. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob. Agents Chemother. 56, 179–188.
Mwangi, M.M., Wu, S.W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E.D., et al. 2008. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 104, 9451–9456.
Nemec, A., Dolzani, L., Brisse, S., van den Broek, P., and Dijkshoorn, L. 2004. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J. Med. Microbiol. 53, 1233–1240.
Neuhauser, M.M., Weinstein, R.A., Rydman, R., Danziger, L.H., Karam, G., and Quinn, J.P. 2003. Antibiotic resistance among Gram-negative bacilli in USintensive care units. JAMA 289, 885–888.
Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264, 382–388.
Nikaido, H. 1998. Antibiotic resistance caused by Gram-negative multidrug efflux pumps. Clin. Infect. Dis. 27 (Suppl 1), S32–41.
Nseir, S., Blazejewski, C., Lubret, R., Wallet, F., Courcol, R., and Durocher, A. 2010. Risk of acquiring multidrug-resistant Gramnegative bacilli from prior room occupants in the intensive care unit. Clin. Microbiol. Infect. 17. 1201–1208.
O’Fallon, E., Gautam, S., and D’Agata, E.M.C. 2009. Colonization with multidrug-resistant Gram-negative bacteria: Prolonged duration and frequent cocolonization. Clin. Infect. Dis. 48. 1375–1381.
O’Fallon, E., Kandel, R., Schreiber, R., and D’Agata, E.M.C. 2010. Acquisition of multidrug-resistant Gram-negative bacteria: incidence and risk factors within a long-term care population. Infect. Control Hosp. Epidemiol. 31, 1148–1153.
Park, Y.K., Choi, J.Y., Jung, S.I., Park, K.H., Lee, H., Jung, D.S., Heo, S.T., Kim, S.W., Chang, H.H., Cheong, H.S., et al. 2009. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn. Microbiol. Infect. Dis. 64, 389–395.
Peleg, A.Y. and Hooper, D.C. 2010. Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 362, 1804–1813.
Rubinstein, E. and Vaughan, D. 2005. Tigecycline: a novel glycylcycline. Drugs 65, 1317–1336.
Shaw, K.J., Rather, P.N., Hare, R.S., and Miller, G.H. 1993. Molecular genetics of aminoglycoside resistance genes and familiar relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57, 138–163.
Skiada, A., Markogiannakis, A., Plachouras, D., and Daikos, G.L. 2011. Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 37, 187–193.
Souli, M., Galani, I., and Giamarellou, H. 2008. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Eurosurveillance 13, 1–11.
Suh, J.Y., Son, J.S., Chung, D.R., Peck, K.R., Ko, K.S., and Song, J.H. 2010. Nonclonal emergence of colistin-resistant Klebsiella pneumonia isolates from blood samples in South Korea. Antimicrob. Agents Chemother. 54, 560–562.
Talbot, G.H., Bradley, J., Edwards, J.E., Gilbert, D., Scheld, M., and Bartlett, J.G. 2006. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42, 657–668.
Top, E.M. and Springael, D. 2003. The role of mobile genetic elements in bacterial adaptation to xenobiotic organic compounds. Curr. Opin. Biotechnol. 14, 262–269.
Tsai, M.H., Chu, S.M., Hsu, J.F., Lien, R., Huang, H.R., Chiang, M.C., Fu, R.H., Lee, C.W., and Huang, Y.C. 2014. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics 133, e322–329.
Wong, P.H.P., von Krosigk, M., Roscoe, D.L., Lau, T.T.Y., Yousefi, M., and Bowie, W.R. 2014. Antimicrobial co-resistance patterns of Gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002–2011. BMC Infect. Dis. 14, 393.
Xiong, Y.Q., Caillon, J., Kergueris, M.F., Drugeon, H., Baron, D., Potel, G., and Bayer, A.S. 1997. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob. Agents Chemother. 41, 823–826.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplemental material for this article may be found at http://www.springerlink.com/content/120956.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Kim, YH. Conditional probability analysis of multidrug resistance in Gram-negative bacilli isolated from tertiary medical institutions in South Korea during 1999–2009. J Microbiol. 54, 50–56 (2016). https://doi.org/10.1007/s12275-016-5579-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-016-5579-9